Clinical Trials Browser

Phase 2 × antineoplaston A10 × Clear all

NCT02742883 2025-09-16

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Phase 2 Suspended

Diffuse Intrinsic Pontine Glioma

NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Phase 2 Completed

34 enrolled 6 charts

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003479 2022-02-23

Antineoplaston Therapy in Treating Patients With Ependymoma

Phase 2 Terminated

9 enrolled 6 charts

Ependymoma

NCT00003487 2021-05-14

Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus

Phase 2 Terminated

8 enrolled 5 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00003508 2021-04-27

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Phase 2 Terminated

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00003498 2021-01-22

Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2 Terminated

5 enrolled 5 charts

Lymphoma, Non-Hodgkin

NCT00003531 2021-01-07

Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer

Phase 2 Terminated

15 enrolled 5 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00003526 2020-12-17

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Phase 2 Terminated

8 enrolled 5 charts

Neoplasms, Unknown Primary

NCT00003456 2018-03-22

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Phase 2 Completed

40 enrolled 6 charts

Glioblastoma

NCT00003471 2018-03-22

Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma

Phase 2 Terminated

7 enrolled 6 charts

Astrocytoma, Recurrence

NCT00003474 2018-03-22

Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme

Phase 2 Completed

40 enrolled 6 charts

Glioblastoma

NCT00003535 2018-03-21

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

Phase 2 Terminated

9 enrolled 6 charts

Astrocytoma, Glioma

NCT00003497 2018-02-05

Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00003500 2018-02-05

Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma

Phase 2 Terminated

Lymphoma, Non-Hodgkin

NCT00003501 2018-02-05

Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma

Phase 2 Terminated

Lymphoma, Non-Hodgkin

NCT00003516 2018-02-05

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00003534 2018-01-31

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00003532 2017-12-12

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00003533 2017-12-12

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00003489 2017-11-21

Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer

Phase 2 Terminated

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

NCT00003530 2017-11-21

Antineoplaston Therapy in Treating Patients With Primary Liver Cancer

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT00003491 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Phase 2 Terminated

Lung Neoplasms

NCT00003515 2017-09-29

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

Phase 2 Terminated

Neuroectodermal Tumors, Primitive

NCT00003520 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003521 2017-09-29

Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma

Phase 2 Terminated

Sarcoma

NCT00003522 2017-09-29

Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine

Phase 2 Terminated

Small Intestine Cancer

NCT00003524 2017-09-29

Antineoplaston Therapy in Treating Patients With Stomach Cancer

Phase 2 Terminated

Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT00003525 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Phase 2 Terminated

Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT00003454 2017-09-28

Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00003496 2017-09-28

Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

Small Cell Lung Carcinoma

NCT00003460 2017-08-24

PNET

Phase 2 Completed

13 enrolled 6 charts

Neuroectodermal Tumors, Primitive

NCT00003469 2017-08-24

Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System

Phase 2 Terminated

4 enrolled 6 charts

Rhabdoid Tumor

NCT00003470 2017-08-24

AA

Phase 2 Completed

27 enrolled 6 charts

Astrocytoma

NCT00003475 2017-08-24

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Phase 2 Completed

40 enrolled 6 charts

Astrocytoma, Glioblastoma

NCT00003476 2017-08-24

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Phase 2 Terminated

8 enrolled 6 charts

Astrocytoma

NCT00003483 2017-08-24

Antineoplaston Therapy in Treating Patients With Meningioma

Phase 2 Terminated

3 enrolled 6 charts

Meningioma

NCT00003537 2017-08-24

AA

Phase 2 Completed

19 enrolled 6 charts

Astrocytoma, Brain Neoplasms

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Phase 2 Completed

40 enrolled 6 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma

NCT02988726 2017-07-26

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

Phase 2 Terminated

Neurilemmoma, Neurofibroma, Central Nervous System Neoplasms

NCT00003455 2013-07-10

Antineoplaston Therapy in Treating Women With Advanced Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT00003486 2013-07-10

Antineoplaston Therapy in Treating Patients With Colon Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT00003502 2013-07-10

Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma

Phase 2 Withdrawn

Lymphoma, Mantle-Cell

NCT00003517 2013-07-10

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms